Table 5.

Trials using ivermectin to reduce malaria transmission through 2023 ordered by the time to first results

Trial name	Lead researcher	Country	Dose	Drug combination	First results
MASSIVE	Umberto D’Alessandro	The Gambia	3 × 300	DHA-P MDA	2020
RIMDAMAL II	Brian Foy	Burkina Faso	3 × 300	Seasonal malaria chemoprevention	2020
TBC	Kobylinski and Sattabongkot	Thailand	1 × 400	Ivermectin alone	2020
TBC	Karine Moiline	Burkina Faso	N/A	Ivermectin to livestock	2020
TBC	Anna Last	Guinea-Bissau	3 × 300	DHA-P MDA	2021
BOHEMIA	Rabinovich and Chaccour	Tanzania and Mozambique	1 × 400	Ivermectin alone + ivermectin to livestock	2021 and 2022

DHA-P = dihydroartemisinin–piperaquine; MDA = mass drug administration; N/A = not-applicable.